V体育安卓版 - "Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
- PMID: 1832904
- DOI: 10.1016/0277-5379(91)90259-g
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
Abstract
The "classical" CMF (cyclophosphamide/methotrexate/5-fluorouracil) schedule was compared with a modified 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer, as concern had arisen as to whether the classical schedule was the optimal way to give these drugs. The response rate with classical CMF was 48% compared with 29% for intravenous CMF (P = 0. 003) VSports手机版. Response duration was similar at 11 months, but survival longer for the classical schedule (17 versus 12 months, P = 0. 016). We conclude that classical CMF is the superior regimen and attribute this to the higher dose intensity achieved. .
Publication types
V体育ios版 - MeSH terms
- Actions (VSports注册入口)
- "V体育2025版" Actions
- Actions (VSports最新版本)
- VSports在线直播 - Actions
- "V体育安卓版" Actions
- Actions (V体育ios版)
- "V体育官网入口" Actions
- Actions (V体育平台登录)
- "VSports在线直播" Actions
- Actions (VSports注册入口)
- Actions (VSports注册入口)
Substances
- Actions (V体育2025版)
- VSports - Actions
Supplementary concepts
LinkOut - more resources
"V体育官网" Medical